Clinical Trial Update: COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide [Phase 1, Phase 2]

View source ↗

Summary

This registry entry describes a Phase 1/2 clinical trial at University of Alabama at Birmingham evaluating combination regimens that include iberdomide to eradi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• iberdomide (iberdomide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING